0001562180-18-001843.txt : 20180404 0001562180-18-001843.hdr.sgml : 20180404 20180404161418 ACCESSION NUMBER: 0001562180-18-001843 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180402 FILED AS OF DATE: 20180404 DATE AS OF CHANGE: 20180404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cloonan Michael CENTRAL INDEX KEY: 0001704336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 18737353 MAIL ADDRESS: STREET 1: C/O SAGE THERAPEUTICS, INC. STREET 2: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-04-02 false 0001597553 Sage Therapeutics, Inc. SAGE 0001704336 Cloonan Michael C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false Chief Business Officer Stock Option (Right to Buy) 145.77 2018-04-02 4 A false 36000.00 0.00 A 2028-04-02 Common Stock 36000.00 36000.00 D The securities awarded on 4/2/2018 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,500 shares of common stock shall vest on the one year anniversary of the 2/1/2018 Vesting Start Date with 13,500 shares vesting in 36 equal monthly installments thereafter. Options to purchase 18,000 shares of common stock shall vest periodically upon the Company achieving certain milestones. /s/ Anne Marie Cook, as Attorney-in-Fact for Michael Cloonan 2018-04-04